Our opinion on the current state of XIIPreviously known as "Go Life International" (GLI), Numeral is a company listed in Mauritius with a secondary listing on the JSE's Alt-X market. Its focus is in "nutraceuticals" which are products associated with alternative medicine. In other words, they are not pharmaceuticals directly, but claim to offer consumers health benefits. The company was formed to acquire and exploit companies in South Africa which produce nutraceuticals. The company currently owns Go Life Health Products and Gotha Health Products. In their results for the six months to 31st August 2023 the company reported zero revenue and a headline loss per share of 0,0051c (US) compared with a loss of 0,0044c in the previous period. The company said, "...the asset base had been completely eroded, which required a full write off of all the underlying investments of $34 851 774 in 2020. The recapitalisation process was completed in the first quarter of 2023. The Board approved subscription agreements for the issue of 465 000 000 new shares, of which 132 500 000 were the treasury shares recovered above." In its financials for the nine months to 30th November 2023 the company reported zero revenue and a headline loss per share of 0,07c (US). The company made a loss of $80777 in the nine months and has negative net asset value (NAV). They have continuously delayed the publication of their financials in the past. Until they can generate revenue and increase the free float and tradability of their shares, we do not believe that they are a practical investment for private investors. On 6th November 2023 the company's board announced that it will propose to change the company's name to "Numeral Limited" from "Go Life International".
